Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: Double-Blind Clinical Trial of Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease [NA]

View source ↗

Summary

A double-blind clinical trial is evaluating subthalamic nucleus deep brain stimulation for early-stage Parkinson disease. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mallory Hacker | Conditions: Parkinson Disease | NA | Status: NOT_YET_RECRUITING